Stealth BioTherapeutics
Newton
About Stealth BioTherapeutics
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. The company was founded in 2007 and is based in Newton, Massachusetts, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $191.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2022)
- Ticker: nasdaq:MITO
- Website: stealthbt.com
- Phone: (617)600-6888
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/stealth-biotherapeutics-44294 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.